mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2024 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.23864
Abstract: The DNA demethylating therapy with azacitidine (AZA) is a promising therapeutic strategy for elderly patients with acute myeloid leukemia (AML). AZA primarily inhibits DNA methylation, promotes cell differentiation and apoptosis in AML. However, as a… read more here.
Keywords: aza; acute myeloid; m5c; mrna m5c ... See more keywords